An astonishing one in five Americans develops nonmelanoma skin cancer (NMSC) at some point in their lifetime; in fact, in the U.S. each year, more people are diagnosed with skin cancer than all other cancers combined. The skin cancer diagnosis typically...
Search Results
The MDMA 2021 FDA Forum Highlights Numerous Advances in Unprecedented Year
The Medical Device Manufacturers Association (MDMA) has been a beacon during the COVID-19 crisis, working closely with the FDA and other key stakeholders to represent the needs of its members and bring innovative devices to patients swiftly but safely. That’s why...
EchoPixel Launches Intraoperative Device; Targets Structural Heart Disease
EchoPixel’s revolutionary technology is rapidly gaining adoption, having already been implemented by over 20 percent of the congenital heart defect programs in the U.S. and used extensively in complex, life-saving surgeries. It has played an essential role in several...
Enspectra Receives Series A Funding; Moves Forward in Widening Market for Skin Cancer Detection Breakthrough
Enspectra Health, a Fogarty Institute company that is leading a digital transformation in skin cancer pathology, recently closed a $7.5 million Series A round led by Tsingyuan Ventures, a technology-focused venture fund based in Los Altos, Calif. Funding success will...
EchoPixel Poised to Revolutionize the Operating Room of the Future
Among the hottest topics in healthcare is the “operating room of the future,” which is on the brink of transformation as new technologies such as artificial intelligence (AI), voice recognition, digital technology and augmented reality are integrated. And at the...
A Better Kind of “Gut Check”
Often referred to as the “second brain,” the gut is garnering increased attention as mounting evidence shows the key role it plays far beyond digesting food in influencing our moods and general health. G-Tech Medical, a Fogarty Institute company, is playing a critical...
Zebra Medical Technologies’ Device Provides an Answer to Deluge of Skin Cancer Screenings
Zebra Medical Technologies' Device Provides an Answer to Deluge of Skin Cancer Screenings American dermatologists experienced 7.5 million office visits for suspected non-melanoma skin cancer in 2017, and a number of factors are indicating these numbers are liable to...
Zebra Medical Technologies poised to disrupt skin cancer detection and treatment
Over the past three decades, skin cancer has become the most prevalent types of cancer, outpacing all other types of cancer combined, including of the breast, lung and prostate. Each year, more than 5.4 million skin tumors are treated in the U.S. alone, with nearly $5...